Division of Transplantation, Department of Transplant Surgery, University of Cincinnati, OH.
Division of Transplantation, Department of Transplant Surgery, University of Cincinnati, OH. Electronic address: https://twitter.com/SJHartmanMD.
Surgery. 2023 Jul;174(1):106-107. doi: 10.1016/j.surg.2023.01.005. Epub 2023 Feb 6.
Colorectal cancer with unresectable liver metastases has significant mortality when treated with chemotherapy alone. In appropriately selected patients, liver transplant is emerging as a treatment alternative for this population. Some key clinical trials, including SECA-I and SECA-II, have shown promising survival results: more trials are being conducted to evaluate safety of this practice.
结直肠癌伴无法切除的肝转移患者单独接受化疗时死亡率较高。在选择适当的患者中，肝移植作为该人群的治疗选择正在出现。一些关键的临床试验，包括 SECA-I 和 SECA-II，已经显示出有希望的生存结果：正在进行更多的试验来评估这种做法的安全性。
